Peugeot shareholders approve autos mega-merger with Fiat
The deal to form the new company called Stellantis was first backed by top investors
Shareholders in Peugeot owner PSA gave the green light on Monday to the French company’s merger with Fiat Chrysler (FCA), one of the last steps towards creating the world’s fourth largest automaker.
At a special shareholder meeting, the deal to form the new company called Stellantis was first backed by top investors with double voting rights, including the Peugeot family, China’s Dongfeng and the French state, via Bpifrance.
All other PSA shareholders backed the deal at a second meeting held online with a 99.85% approval rate among votes cast. FCA investors are due to give their verdict later on Monday.
“We are ready for this merger,” PSA Chief Executive Carlos Tavares said, adding that the date for the closure of the deal would be announced shortly if all shareholder approvals were granted. He said the deal had now passed all regulatory tests.
The shareholding structure will be altered as part of the merger, and existing double voting rights - which are accrued over time and give investors more weight in decisions - will not be carried over.
Tavares, who will take the helm of the merged group, will have to revive the carmaker’s fortunes in China, rationalise a sprawling global empire and address massive overcapacity, as well as focus like rivals on creating cleaner cars.
Stellantis will have 14 brands, from FCA’s Fiat, Maserati and U.S.-focused Jeep, Dodge and Ram to PSA’s Peugeot, Citroen, Opel and DS. PSA has traditionally been more focused on Europe. — Reuters
Real estate, infrastructure likely to stand out as biggest... READ MORE
Brent, WTI set for weekly gains of about 5 per cent READ MORE
European share markets were set to follow Asia higher. READ MORE
At the interbank foreign exchange market, the Indian unit traded in a ... READ MORE
Dr Nawal noted that mutations are common in SARS-CoV-2 — an RNA ... READ MORE
The UAE's vaccine administration rates are just second behind Israel... READ MORE
Experts studying the data from clinical trials say volunteers who had ... READ MORE
More than 23 million tests have been carried out across the country... READ MORE